Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19.
Identifieur interne : 001297 ( Main/Corpus ); précédent : 001296; suivant : 001298Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19.
Auteurs : Benjamin Valente-Acosta ; Francisco Moreno-Sanchez ; Omar Fueyo-Rodriguez ; Andres Palomar-LeverSource :
- BMJ case reports [ 1757-790X ] ; 2020.
English descriptors
- KwdEn :
- Aged (MeSH), Anti-Bacterial Agents (therapeutic use), Antibodies, Monoclonal, Humanized (therapeutic use), Anticoagulants (therapeutic use), Azithromycin (therapeutic use), Betacoronavirus (MeSH), Bicarbonates (therapeutic use), COVID-19 (MeSH), Ceftriaxone (therapeutic use), Coronavirus Infections (complications), Coronavirus Infections (diagnostic imaging), Coronavirus Infections (therapy), Cytochrome P-450 CYP3A Inhibitors (therapeutic use), Enoxaparin (therapeutic use), Enzyme Inhibitors (therapeutic use), Fluid Therapy (MeSH), Humans (MeSH), Hydroxychloroquine (therapeutic use), Lopinavir (therapeutic use), Lung (diagnostic imaging), Male (MeSH), Pandemics (MeSH), Pneumonia, Viral (complications), Pneumonia, Viral (diagnostic imaging), Pneumonia, Viral (therapy), Respiration, Artificial (MeSH), Rhabdomyolysis (diagnosis), Rhabdomyolysis (etiology), Rhabdomyolysis (therapy), Ritonavir (therapeutic use), SARS-CoV-2 (MeSH), Tomography, X-Ray Computed (methods), Treatment Outcome (MeSH).
- MESH :
- chemical , therapeutic use : Anti-Bacterial Agents, Antibodies, Monoclonal, Humanized, Anticoagulants, Azithromycin, Bicarbonates, Ceftriaxone, Cytochrome P-450 CYP3A Inhibitors, Enoxaparin, Enzyme Inhibitors, Hydroxychloroquine, Lopinavir, Ritonavir.
- complications : Coronavirus Infections, Pneumonia, Viral.
- diagnosis : Rhabdomyolysis.
- diagnostic imaging : Coronavirus Infections, Lung, Pneumonia, Viral.
- etiology : Rhabdomyolysis.
- methods : Tomography, X-Ray Computed.
- therapy : Coronavirus Infections, Pneumonia, Viral, Rhabdomyolysis.
- Aged, Betacoronavirus, COVID-19, Fluid Therapy, Humans, Male, Pandemics, Respiration, Artificial, SARS-CoV-2, Treatment Outcome.
Abstract
The presence of rhabdomyolysis secondary to multiple infections has been reported, predominantly viral, but also bacterial and fungal. It is well known that COVID-19 can present a wide variety of complications during the course of infection; however, the presence of rhabdomyolysis as an initial condition has not been reported so far. We report a case of rhabdomyolysis as an initial presentation in a patient diagnosed with SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection.
DOI: 10.1136/bcr-2020-236719
PubMed: 32587121
PubMed Central: PMC7319710
Links to Exploration step
pubmed:32587121Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19.</title><author><name sortKey="Valente Acosta, Benjamin" sort="Valente Acosta, Benjamin" uniqKey="Valente Acosta B" first="Benjamin" last="Valente-Acosta">Benjamin Valente-Acosta</name><affiliation><nlm:affiliation>Internal Medicine and Infectious Diseases, Centro Medico ABC, Ciudad de México, Mexico City, Mexico benjamin.valente-acosta1@alumni.lshtm.ac.uk.</nlm:affiliation></affiliation></author><author><name sortKey="Moreno Sanchez, Francisco" sort="Moreno Sanchez, Francisco" uniqKey="Moreno Sanchez F" first="Francisco" last="Moreno-Sanchez">Francisco Moreno-Sanchez</name><affiliation><nlm:affiliation>Internal Medicine and Infectious Diseases, Centro Medico ABC, Ciudad de México, Mexico City, Mexico.</nlm:affiliation></affiliation></author><author><name sortKey="Fueyo Rodriguez, Omar" sort="Fueyo Rodriguez, Omar" uniqKey="Fueyo Rodriguez O" first="Omar" last="Fueyo-Rodriguez">Omar Fueyo-Rodriguez</name><affiliation><nlm:affiliation>Internal Medicine and Infectious Diseases, Centro Medico ABC, Ciudad de México, Mexico City, Mexico.</nlm:affiliation></affiliation></author><author><name sortKey="Palomar Lever, Andres" sort="Palomar Lever, Andres" uniqKey="Palomar Lever A" first="Andres" last="Palomar-Lever">Andres Palomar-Lever</name><affiliation><nlm:affiliation>Pulmonary Medicine, Centro Medico ABC, Mexico City, Mexico.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32587121</idno><idno type="pmid">32587121</idno><idno type="doi">10.1136/bcr-2020-236719</idno><idno type="pmc">PMC7319710</idno><idno type="wicri:Area/Main/Corpus">001297</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001297</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19.</title><author><name sortKey="Valente Acosta, Benjamin" sort="Valente Acosta, Benjamin" uniqKey="Valente Acosta B" first="Benjamin" last="Valente-Acosta">Benjamin Valente-Acosta</name><affiliation><nlm:affiliation>Internal Medicine and Infectious Diseases, Centro Medico ABC, Ciudad de México, Mexico City, Mexico benjamin.valente-acosta1@alumni.lshtm.ac.uk.</nlm:affiliation></affiliation></author><author><name sortKey="Moreno Sanchez, Francisco" sort="Moreno Sanchez, Francisco" uniqKey="Moreno Sanchez F" first="Francisco" last="Moreno-Sanchez">Francisco Moreno-Sanchez</name><affiliation><nlm:affiliation>Internal Medicine and Infectious Diseases, Centro Medico ABC, Ciudad de México, Mexico City, Mexico.</nlm:affiliation></affiliation></author><author><name sortKey="Fueyo Rodriguez, Omar" sort="Fueyo Rodriguez, Omar" uniqKey="Fueyo Rodriguez O" first="Omar" last="Fueyo-Rodriguez">Omar Fueyo-Rodriguez</name><affiliation><nlm:affiliation>Internal Medicine and Infectious Diseases, Centro Medico ABC, Ciudad de México, Mexico City, Mexico.</nlm:affiliation></affiliation></author><author><name sortKey="Palomar Lever, Andres" sort="Palomar Lever, Andres" uniqKey="Palomar Lever A" first="Andres" last="Palomar-Lever">Andres Palomar-Lever</name><affiliation><nlm:affiliation>Pulmonary Medicine, Centro Medico ABC, Mexico City, Mexico.</nlm:affiliation></affiliation></author></analytic><series><title level="j">BMJ case reports</title><idno type="eISSN">1757-790X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term><term>Anti-Bacterial Agents (therapeutic use)</term><term>Antibodies, Monoclonal, Humanized (therapeutic use)</term><term>Anticoagulants (therapeutic use)</term><term>Azithromycin (therapeutic use)</term><term>Betacoronavirus (MeSH)</term><term>Bicarbonates (therapeutic use)</term><term>COVID-19 (MeSH)</term><term>Ceftriaxone (therapeutic use)</term><term>Coronavirus Infections (complications)</term><term>Coronavirus Infections (diagnostic imaging)</term><term>Coronavirus Infections (therapy)</term><term>Cytochrome P-450 CYP3A Inhibitors (therapeutic use)</term><term>Enoxaparin (therapeutic use)</term><term>Enzyme Inhibitors (therapeutic use)</term><term>Fluid Therapy (MeSH)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (therapeutic use)</term><term>Lopinavir (therapeutic use)</term><term>Lung (diagnostic imaging)</term><term>Male (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (complications)</term><term>Pneumonia, Viral (diagnostic imaging)</term><term>Pneumonia, Viral (therapy)</term><term>Respiration, Artificial (MeSH)</term><term>Rhabdomyolysis (diagnosis)</term><term>Rhabdomyolysis (etiology)</term><term>Rhabdomyolysis (therapy)</term><term>Ritonavir (therapeutic use)</term><term>SARS-CoV-2 (MeSH)</term><term>Tomography, X-Ray Computed (methods)</term><term>Treatment Outcome (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term><term>Antibodies, Monoclonal, Humanized</term><term>Anticoagulants</term><term>Azithromycin</term><term>Bicarbonates</term><term>Ceftriaxone</term><term>Cytochrome P-450 CYP3A Inhibitors</term><term>Enoxaparin</term><term>Enzyme Inhibitors</term><term>Hydroxychloroquine</term><term>Lopinavir</term><term>Ritonavir</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Rhabdomyolysis</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Coronavirus Infections</term><term>Lung</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Rhabdomyolysis</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Tomography, X-Ray Computed</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term><term>Rhabdomyolysis</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Betacoronavirus</term><term>COVID-19</term><term>Fluid Therapy</term><term>Humans</term><term>Male</term><term>Pandemics</term><term>Respiration, Artificial</term><term>SARS-CoV-2</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The presence of rhabdomyolysis secondary to multiple infections has been reported, predominantly viral, but also bacterial and fungal. It is well known that COVID-19 can present a wide variety of complications during the course of infection; however, the presence of rhabdomyolysis as an initial condition has not been reported so far. We report a case of rhabdomyolysis as an initial presentation in a patient diagnosed with SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32587121</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>06</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1757-790X</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>24</Day></PubDate></JournalIssue><Title>BMJ case reports</Title><ISOAbbreviation>BMJ Case Rep</ISOAbbreviation></Journal><ArticleTitle>Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e236719</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bcr-2020-236719</ELocationID><Abstract><AbstractText>The presence of rhabdomyolysis secondary to multiple infections has been reported, predominantly viral, but also bacterial and fungal. It is well known that COVID-19 can present a wide variety of complications during the course of infection; however, the presence of rhabdomyolysis as an initial condition has not been reported so far. We report a case of rhabdomyolysis as an initial presentation in a patient diagnosed with SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection.</AbstractText><CopyrightInformation>© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Valente-Acosta</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-9885-3594</Identifier><AffiliationInfo><Affiliation>Internal Medicine and Infectious Diseases, Centro Medico ABC, Ciudad de México, Mexico City, Mexico benjamin.valente-acosta1@alumni.lshtm.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno-Sanchez</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Internal Medicine and Infectious Diseases, Centro Medico ABC, Ciudad de México, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fueyo-Rodriguez</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Internal Medicine and Infectious Diseases, Centro Medico ABC, Ciudad de México, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palomar-Lever</LastName><ForeName>Andres</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pulmonary Medicine, Centro Medico ABC, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Case Rep</MedlineTA><NlmUniqueID>101526291</NlmUniqueID><ISSNLinking>1757-790X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D061067">Antibodies, Monoclonal, Humanized</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001639">Bicarbonates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D065692">Cytochrome P-450 CYP3A Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017984">Enoxaparin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>2494G1JF75</RegistryNumber><NameOfSubstance UI="D061466">Lopinavir</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>75J73V1629</RegistryNumber><NameOfSubstance UI="D002443">Ceftriaxone</NameOfSubstance></Chemical><Chemical><RegistryNumber>83905-01-5</RegistryNumber><NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance></Chemical><Chemical><RegistryNumber>I031V2H011</RegistryNumber><NameOfSubstance UI="C502936">tocilizumab</NameOfSubstance></Chemical><Chemical><RegistryNumber>O3J8G9O825</RegistryNumber><NameOfSubstance UI="D019438">Ritonavir</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061067" MajorTopicYN="N">Antibodies, Monoclonal, Humanized</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001639" MajorTopicYN="N">Bicarbonates</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002443" MajorTopicYN="N">Ceftriaxone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065692" MajorTopicYN="N">Cytochrome P-450 CYP3A Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017984" MajorTopicYN="N">Enoxaparin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061466" MajorTopicYN="N">Lopinavir</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012206" MajorTopicYN="N">Rhabdomyolysis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019438" MajorTopicYN="N">Ritonavir</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">pneumonia (infectious disease)</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32587121</ArticleId><ArticleId IdType="pii">13/6/e236719</ArticleId><ArticleId IdType="doi">10.1136/bcr-2020-236719</ArticleId><ArticleId IdType="pmc">PMC7319710</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ann Lab Med. 2014 Jul;34(4):263-73</Citation><ArticleIdList><ArticleId IdType="pubmed">24982830</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 May 13;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Nephrol. 2020 Aug;35(8):1517-1520</Citation><ArticleIdList><ArticleId IdType="pubmed">32447505</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect. 2020 Apr 23;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32335169</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2008 Mar;36(3):941-52</Citation><ArticleIdList><ArticleId IdType="pubmed">18431284</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1992 Nov;42(11):2082-7</Citation><ArticleIdList><ArticleId IdType="pubmed">1436516</ArticleId></ArticleIdList></Reference><Reference><Citation>Cureus. 2020 Apr 6;12(4):e7561</Citation><ArticleIdList><ArticleId IdType="pubmed">32382463</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2020 Jul;26(7):1618-1620</Citation><ArticleIdList><ArticleId IdType="pubmed">32197060</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation><ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Case Rep. 2018 Dec 4;11(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">30567189</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Clin Pract. 2005 Oct;59(10):1162-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16178983</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2020 Jul;98(1):219-227</Citation><ArticleIdList><ArticleId IdType="pubmed">32327202</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001297 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001297 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32587121
|texte= Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32587121" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |